跳至主要内容
临床试验/CTIS2024-513845-36-00
CTIS2024-513845-36-00招募中1 期

SNT-I-VAM-025

Santhera Pharmaceuticals (Schweiz) AG0 个研究点目标入组 18 人开始时间: 2024年6月7日最近更新:

试验速览

阶段
1 期
状态
招募中
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

相似试验

进行中(未招募)
1 期
A study to investigate VMX-C001 in healthy volunteers.To restore coagulation in patients taking DOACs who are experiencing bleeding or who require reversal of anticoagulation prior to urgent surgery.MedDRA version: 20.0Level: PTClassification code: 10009773Term: Coagulation factor X level Class: 100000004848
CTIS2024-514339-87-00VarmX B.V.12
招募中
1 期
Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women with Recurrent Vulvovaginal Candidiasis: A Randomized Controlled StudyMedDRA version: 20.1Level: PTClassification code: 10047784Term: Vulvovaginal candidiasis Class: 100000004862Recurrent vulvovaginal candidiasis
CTIS2023-507527-28-00immaTech Biologics AG251
进行中(未招募)
1 期
A Phase 1, Open-Label, Non-Randomized, Single-Center, Single-Dose Study to Assess the Pharmacokinetics and Safety of ANT3310 Combined with Meropenem Administered as a Single Intravenous Infusion to Adult Subjects with Renal Function ImpairmentRenal impairment
CTIS2024-512617-41-00Antabio48
进行中(未招募)
1 期
A Phase 1b Study to Characterize the Safety and Tolerability of TEV-53408 in Adults with Celiac DiseaseCeliac disease
CTIS2022-502817-27-00Teva Branded Pharmaceutical Products R&D Inc.20
进行中(未招募)
1 期
Effects of NT-0796 in Healthy Volunteers and Patients with Parkinson’s DiseaseMedDRA version: 21.1Level: LLTClassification code: 10013113Term: Disease Parkinson's Class: 10029205Parkinson's Disease
CTIS2023-503203-29-00odthera Limited14